Australia markets open in 7 hours 44 minutes

GT Biopharma, Inc. (GTBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6300-0.2000 (-7.07%)
As of 12:14PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-33,322
-7,597
-20,884
-58,013
-28,296
-
Depreciation & amortisation
12
-
-
-
0
4
Stock-based compensation
14,337
2,200
7,646
33,929
269
-
Change in working capital
4,458
1,825
-1,989
7,940
2,404
-
Accounts payable
4,532
-
-2,030
7,077
-838
3,154
Other working capital
-14,624
-8,852
-15,217
-15,606
-7,262
-
Other non-cash items
70
112
130
720
17,978
-
Net cash provided by operating activities
-14,624
-8,852
-15,217
-15,606
-7,262
-
Cash flows from investing activities
Purchases of investments
-
-
-
-23,040
0
-
Net cash used for investing activities
7,630
-2,009
12,145
-23,040
0
-
Cash flows from financing activities
Debt repayment
-
-
-
-
0
-100
Common stock issued
0
6,268
0
24,679
0
-
Common stock repurchased
-
0
-224
0
-
-
Net cash used provided by (used for) financing activities
-223
6,268
-224
42,317
12,531
-
Net change in cash
-7,217
-4,593
-3,296
3,671
5,269
-
Cash at beginning of period
9,682
5,672
8,968
5,297
28
-
Cash at end of period
2,465
1,079
5,672
8,968
5,297
-
Free cash flow
Operating cash flow
-14,624
-8,852
-15,217
-15,606
-7,262
-
Free cash flow
-14,624
-8,852
-15,217
-15,606
-7,262
-